SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-20-009778
Filing Date
2020-03-10
Accepted
2020-03-10 16:48:07
Documents
4
Effectiveness Date
2020-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 kalv-s8.htm S-8 98671
2 EX-5.1 kalv-ex51_8.htm EX-5.1 14475
3 EX-23.1 kalv-ex231_6.htm EX-23.1 2319
4 EX-99.4 kalv-ex994_35.htm EX-99.4 60732
  Complete submission text file 0001564590-20-009778.txt   177527
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-237059 | Film No.: 20702297
SIC: 2834 Pharmaceutical Preparations